In 353 neonates, foot length were recorded along with birth weight, crown heel length and head circumference. Foot length correlated well with all three indices (p less than .01). Highest correlation in preterm babies was with crown heel length and weight, and in term babies with head circumference. The formula, length = footlength x 6.5 +/- 20 mm could be correctly used in 95% of babies. When it is difficult to weigh or measure the length accurately, foot length can serve as a useful measurement to assess a baby quickly.

No abstract

The present study suggests that oral Montelukast is not inferior to Budesonide in treatment of mild persistent asthma in 2 to 18 y children in terms of control of symptoms and improvement in pulmonary function tests over a 12 wk period. However, there was more significant improvement in day time symptoms, more significant increase in FEV1/FVC ratio and less exacerbation in patients receiving Budesonide compared to those receiving Montelukast. However, side effects due to long term use of steroids such as growth stunting and bone osteopenia should also be considered before recommending. Trial registered at CTRI no. REF/2012/09/004035.

Aims: To study the anthropometric measurements of the neonates between 28 to 42 weeks of gestational age. To express them as smoothed percentiles and obtain their correlation with the constant.  Comparing the data trend with the Shah Study conducted twelve years ago in the same institute. Study Design: Cross-sectional observational study of 500 (selected out of 1223 by convenience sampling) live new-borns, 28 to 42 weeks gestational age (confirmed by Ballard score) was conducted in NICU and post-natal ward, Sir-T hospital, Bhavnagar. Infantometer and non-stretchable measuring tape were used for measurements.  Results: Demographic data- female, male: [247 (49.4%), 253 (50.6%)]. The newborns weighing < 2.499 kg were n= 193(38.6%), 2.500- 3.00 kg n=247(49.4%) and > 3.00 kg n= 60(12%). 244 newborns were <37 weeks old (48.8%) and 256 were 37- 42 weeks old (51.2%), with 37 weeks old contributing n=167(33.4%). The male newborn had higher anthropometric variable than female: Weight, Crown Heel Length, Head Circumference, Chest Circumference, Ponderal Index, Thigh Circumference, Mid Arm Circumference, Foot Length were 2.500, 46.73, 31.65, 29.69, 2.38, 12.06, 8.4, 6.79 of female and 2.595, 47.43, 32.08, 29.95, 2.39, 12.19, 8.2, 7.13 of male respectively, except in MAC. By comparing the mean of the parameters of 34 to 38 week newborns, the mean of TC and MAC of the present study was found to be increased than in Shah Study. Similarly, the mean of weight in 34, 36, 37 and 38, CHL in 36 and 38, the HC  in 36, 37 and 38, the CC in 34, 35, 36 and 37, the FL in 35 and 37, and the Ponderal Index in 34, 35 and 38 week newborns, of present study was increased, as compared to Shah Study. By Pearson’s correlation, the maximum association was found with TC (r 0.934), followed by PI (0.868) and HC (0.844) in the present study and with TC (0.966) in Shah Study. The intrauterine growth curves were constructed by plotting percentile values of each anthropometric parameter against gestational age in weeks. Conclusion: The nutrition has improved in the near term and full-term neonates. The percentile charts constructed in accordance with current data trends thus can be utilised regionally.

Objective: To study the effect and safety of Fenofibrate in uncomplicated hyperbilirubinemia in newborn with 6-month follow-up. Materials and Methods: This is a randomized controlled clinical trial conducted in 60 normal term neonates admitted for uncomplicated hyperbilirubinemia in NICU at Sir T G Hospital, Bhavnagar from January 2012 to December 2012. The data included: age, sex, total serum bilirubin (TSB), weight and duration of phototherapy. All neonates enrolled in the study received phototherapy. They were divided in two groups of 30 each: control group A and group B receiving Fenofibrate (100 mg/kg single dose). There was statistically insignificant difference between the parameters of age, sex, weight and TSB between the two groups at hospitalization. Data was analyzed by using appropriate statistical methods. Results: Mean values for total serum bilirubin in Fenofibrate group B at 24 and 48 hours after admission were significantly lower than those for control group A (p<0.0001,  p=0.0001). There was no significant difference in fall of TSB between 24 and 48 hours. The mean duration of phototherapy in Fenofibrate group (44.8h: 24-72h) was significantly shorter than that in control group (55.2 h: 24‐96 h) (P=0.02). There were no side effects of the drug observed during the study and during 6 months follow up period. Conclusion: Fenofibrate as a single 100 mg/kg dose in healthy full term neonates, is effective and a safe drug (till six-month follow-up) for neonatal hyperbilirubinemia, that can decrease the time needed for phototherapy and hence hospitalization. Effect of a single dose seems to wane after 24 hours.